Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy

Colorectal cancer is the second leading cause of cancer death globally. The gold standard for locally advanced rectal cancer (LARC) nowadays is preoperative concurrent chemoradiation (CCRT). Approximately three quarters of LARC patients do not achieve pathological complete response and hence suffer...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hsin-Hua, Chen, Chien-Hung, Huang, Yu-Hsiang, Chiang, Cheng-Han, Huang, Ming-Yii
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139800/
https://www.ncbi.nlm.nih.gov/pubmed/35626648
http://dx.doi.org/10.3390/cells11101611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139800/
https://www.ncbi.nlm.nih.gov/pubmed/35626648
http://dx.doi.org/10.3390/cells11101611

Ejemplares similares